|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ren G, Cai R, Zhang WJ, Ou JM, Jin YN and
Li WH: Prediction of risk factors for lymph node metastasis in
early gastric cancer. World J Gastroenterol. 19:3096–3107. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lagergren J, Andersson G, Talbäck M,
Drefahl S, Bihagen E, Härkönen J, Feychting M and Ljung R: Marital
status, education, and income in relation to the risk of esophageal
and gastric cancer by histological type and site. Cancer.
122:207–212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brosens LA, Wood LD, Offerhaus GJ, Arnold
CA, Lam-Himlin D, Giardiello FM and Montgomery EA: Pathology and
genetics of syndromic gastric polyps. Int J Surg Pathol.
24:185–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krishnaveni D, Bhayal AC, Shravan KP,
Jyothy A, Pratibha N and Venkateshwari A: Heterozygosity of
stromelysin-1 (rs3025058) promoter polymorphism is associated with
gastric cancer. Indian J Cancer. 52:251–254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thutkawkorapin J, Picelli S, Kontham V,
Liu T, Nilsson D and Lindblom A: Exome sequencing in one family
with gastric- and rectal cancer. BMC Genet. 17:412016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ushiku T, Ishikawa S, Kakiuchi M, Tanaka
A, Katoh H, Aburatani H, Lauwers GY and Fukayama M: RHOA mutation
in diffuse-type gastric cancer: A comparative clinicopathology
analysis of 87 cases. Gastric Cancer. 19:403–411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan X, Wang H, Luo G, Ren S, Li W, Cui J,
Gill HS, Fu SW and Lu Y: Clinical significance of a point mutation
in DNA polymerase beta (POLB) gene in gastric cancer. Int J Biol
Sci. 11:144–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Ren C, Han C, Wang D, Chen Y and
Fu D: Expression and prognostic value of miR-486-5p in patients
with gastric adenocarcinoma. PLoS One. 10:e01193842015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang W, Tong JH, Lung RW, Dong Y, Zhao J,
Liang Q, Zhang L, Pan Y, Yang W, Pang JC, et al: Targeting of YAP1
by microRNA-15a and microRNA-16-1 exerts tumor suppressor function
in gastric adenocarcinoma. Mol Cancer. 14:522015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minn YK, Lee DH, Hyung WJ, Kim JE, Choi J,
Yang SH, Song H, Lim BJ and Kim SH: MicroRNA-200 family members and
ZEB2 are associated with brain metastasis in gastric
adenocarcinoma. Int J Oncol. 45:2403–2410. 2014.PubMed/NCBI
|
|
15
|
Wang S, Lv C, Jin H, Xu M, Kang M, Chu H,
Tong N, Wu D, Zhu H, Gong W, et al: A common genetic variation in
the promoter of miR-107 is associated with gastric adenocarcinoma
susceptibility and survival. Mutat Res. 769:35–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
17
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benesty J, Chen J, Huang Y and Cohen I:
Pearson correlation coefficientNoise Reduction in Speech
Processing. 2. 1st. Springer; Heidelberg: pp. 1–4. 2009, View Article : Google Scholar
|
|
19
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashimoto K, Goto S, Kawano S,
Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T and Kanehisa M:
KEGG as a glycome informatics resource. Glycobiology. 16:63R–70R.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eden E, Navon R, Steinfeld I, Lipson D and
Yakhini Z: GOrilla: A tool for discovery and visualization of
enriched GO terms in ranked gene lists. BMC Bioinformatics.
10:482009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Dai X, Chen Y, Sun C, Zhu Q, Zhao
H, Liu G, Huang Q and Lan Q: MiR-30a-5p is induced by Wnt/β-catenin
pathway and promotes glioma cell invasion by repressing NCAM.
Biochem Biophys Res Commun. 465:374–380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Igci YZ, Ozkaya M, Korkmaz H, Bozgeyik E,
Bayraktar R, Ulasli M, Erkilic S, Eraydin A and Oztuzcu S:
Expression levels of miR-30a-5p in papillary thyroid carcinoma: A
comparison between serum and fine needle aspiration biopsy samples.
Genet Test Mol Biomarkers. 19:418–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen
Y, Wang J, Liu Y, Chen P, Wu X and Wen J: Urinary microRNA-30a-5p
is a potential biomarker for ovarian serous adenocarcinoma. Oncol
Rep. 33:2915–2923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li FQ, Xu B, Wu YJ, Yang ZL and Qian JJ:
Differential microRNA expression in signet-ring cell carcinoma
compared with tubular adenocarcinoma of human gastric cancer. Genet
Mol Res. 14:739–747. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsukasa K, Ding Q, Miyazaki Y, Matsubara
S, Natsugoe S and Takao S: miR-30 family promotes migratory and
invasive abilities in CD133(+) pancreatic cancer stem-like cells.
Human Cell. 29:130–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang HY, Li YY, Fu S, Wang XP, Huang MY,
Zhang X, Shao Q, Deng L, Zeng MS, Zeng YX and Shao JY: MicroRNA-30a
promotes invasiveness and metastasis in vitro and in vivo through
epithelial-mesenchymal transition and results in poor survival of
nasopharyngeal carcinoma patients. Exp Biol Med (Maywood).
239:891–898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stánitz E, Juhász K, Tóth C, Gombos K,
Natali PG and Ember I: Evaluation of MicroRNA expression pattern of
gastric adenocarcinoma associated with socioeconomic, environmental
and lifestyle factors in northwestern Hungary. Anticancer Res.
33:3195–3200. 2013.PubMed/NCBI
|
|
29
|
Zhuang M, Shi Q, Zhang X, Ding Y, Shan L,
Shan X, Qian J, Zhou X, Huang Z, Zhu W, et al: Involvement of
miR-143 in cisplatin resistance of gastric cancer cells via
targeting IGF1R and BCL2. Tumour Biol. 36:2737–2745. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA-143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP,
Zhang LF, Zhu GB and Shen X: Potentially predictive microRNAs of
gastric cancer with metastasis to lymph node. World J
Gastroenterol. 17:3645–3651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vidal AF, Cruz AMP, Magalhães L, Pereira
AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S
and Ribeiro-dos-Santos Â: Hsa-miR-29c and hsa-miR-135b differential
expression as potential biomarker of gastric carcinogenesis. World
J Gastroenterol. 22:2060–2070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lulli V, Buccarelli M, Martini M, Signore
M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R,
Pagliuca A, et al: miR-135b suppresses tumorigenesis in
glioblastoma stem-like cells impairing proliferation, migration and
self-renewal. Oncotarget. 6:37241–37256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao S, Yang Z, Lv R, Zhao J, Wu M, Liao Y
and Liu Q: miR-135b contributes to the radioresistance by targeting
GSK3β in human glioblastoma multiforme cells. PLoS One.
9:e1088102014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Zhang G, Li J, Liu J and Lv P: The
tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma.
PLoS One. 9:e1026212014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khalili M, Vasei M, Khalili D,
Alimoghaddam K, Sadeghizadeh M and Mowla SJ: Downregulation of the
genes involved in reprogramming (SOX2, c-MYC, miR-302, miR-145 and
P21) in gastric adenocarcinoma. J Gastrointest Cancer. 46:251–258.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo L, Bai H, Zou D, Hong T, Liu J, Huang
J, He P, Zhou Q and He J: The role of microRNA-133b and its target
gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 33:992014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen JJ, Cai WY, Liu XW, Luo QC, Chen G,
Huang WF, Li N and Cai JC: Reverse correlation between MicroRNA-145
and FSCN1 affecting gastric cancer migration and invasion. PLoS
One. 10:e01268902015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Zhang X, Zhang Y, Hu Z, Yang D,
Wang C, Guo M and Cai Q: Identification of miRNomes in human
stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic
target for gastric cancer. Cancer Lett. 369:58–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
